Please add info@sitcancer.org to your safe senders list. ![]() |
|||||
|
|||||
August 18, 2014 Online Advance Registration Closes Tomorrow for SITC's Register now to ensure your spot! Friday, August 22, 2014, 8:00 am - 3:30 pm
Are you or someone you know looking for more information on the ground-breaking cancer treatment options that use the power of the immune system? Time is running out to register for SITC's introductory, CME-certified Advances in Cancer ImmunotherapyTM program in La Jolla, California. Online registration ends tomorrow, August 19, 2014 at 11:59 pm PDT. Who Should Attend The target audience for these programs includes clinical oncologists, those involved in patient care, early career individuals, allied health professionals, and patient advocates who wish to learn principles of tumor immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients. Program Purpose Presented by leading authorities in tumor immunology and cancer immunotherapy, these programs will facilitate an understanding of:
Remember! Within 4-6 weeks of the program, attendees will have free online access to program slides. CME Credits Available The Clinical Immunology Society designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. For full accreditation information, click on the CME button above or visit: www.sitcancer.org/sitc-meetings/aci2014/ca/aci-ca-cme-information. Program Organizers • Gregory A. Daniels, MD, PhD – University of California San Diego Cancer Center Save More on Program Registration by Becoming a SITC Member Join SITC's unique membership made up of over 800 leading professionals from industry, academia, and government to receive discounted registration rates on all SITC programs. Other membership benefits include:
To apply for membership, please click here. |
|||||
Society for Immunotherapy of Cancer (SITC) © 2014 Society for Immunotherapy of Cancer Join us on: You have received this message because you have had previous contact with the Society for Immunotherapy of Cancer. If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line. Please add info@sitcancer.org to your safe senders list. |